Clinical trials
Recruiting Triple Negative Breast Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
148 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 14 |
| 2022 | 15 |
| 2023 | 19 |
| 2024 | 28 |
| 2025 | 37 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 148 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| H. Lee Moffitt Cancer Center and Research Institute | 5 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Emory University | 4 |
| UNC Lineberger Comprehensive Cancer Center | 4 |
| Bristol-Myers Squibb | 3 |
| Eli Lilly and Company | 3 |
| Gilead Sciences | 3 |
| M.D. Anderson Cancer Center | 3 |
| Merck Sharp & Dohme LLC | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 148 |
| Breast Neoplasms | 63 |
| Carcinoma, Non-Small-Cell Lung | 44 |
| Squamous Cell Carcinoma of Head and Neck | 28 |
| Ovarian Neoplasms | 23 |
| Endometrial Neoplasms | 21 |
| Colorectal Neoplasms | 19 |
| Melanoma | 17 |
| Uterine Cervical Neoplasms | 17 |
| Neoplasm Metastasis | 16 |
Trials
Showing 1 to 25 of 148. Each trial links to its page on Pharma Observatory.
48 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.